dorsaVi (ASX:DVL) appointed Mathew Regan as group chief executive, effective Nov. 1, according to a Thursday Australian bourse filing.
Regan previously served as CEO of Artrya (ASX:AYA), per the filing.
Andrew Ronchi will continue as CEO of the company's sensor division, the filing added.
dorsaVi's shares rose past 2% in recent Thursday trade, while Artrya's shares fell 4%.